Literature DB >> 7603011

Cell counts in peripheral blood and bone marrow of male C.B-17 scid/scid mice.

K Matsumoto1, S Inukai, T Isaka, N Aruga, S Nakamura, T Nagasawa, J Naito.   

Abstract

Blood cell and bone marrow cell counts were carried out for male C.B-17 scid/scid (SCID) mice aged 3, 6, 9, 18 and 26 weeks and the values were compared with those in C.B-17 +/+ (C.B-17) mice. In the peripheral blood, SCID mice had markedly low numbers of leucocytes and lymphocytes throughout the study. In the bone marrow, SCID mice had relatively low levels of erythroblasts at an early age, low levels of lymphocytes and plasma cells were absent.

Entities:  

Mesh:

Year:  1995        PMID: 7603011     DOI: 10.1258/002367795780740230

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  4 in total

1.  Creating effective biocontainment facilities and maintenance protocols for raising specific pathogen-free, severe combined immunodeficient (SCID) pigs.

Authors:  Ellis J Powell; Sara Charley; Adeline N Boettcher; Lisa Varley; Justin Brown; Martine Schroyen; Malavika K Adur; Susan Dekkers; Dean Isaacson; Mary Sauer; Joan Cunnick; N Matthew Ellinwood; Jason W Ross; Jack Cm Dekkers; Christopher K Tuggle
Journal:  Lab Anim       Date:  2018-01-11       Impact factor: 2.471

2.  The humanin analogue (HNG) prevents temozolomide-induced male germ cell apoptosis and other adverse effects in severe combined immuno-deficiency (SCID) mice bearing human medulloblastoma.

Authors:  Yue Jia; Yanhe Lue; Ronald S Swerdloff; Joseph L Lasky; Eduard H Panosyan; Jenny Dai-Ju; Christina Wang
Journal:  Exp Mol Pathol       Date:  2019-05-11       Impact factor: 4.401

3.  Identification of cross-reactive antibodies for the detection of lymphocytes, myeloid cells and haematopoietic precursors in the naked mole rat.

Authors:  Yury Shebzukhov; Susanne Holtze; Heike Hirseland; Hubert Schäfer; Andreas Radbruch; Thomas Hildebrandt; Andreas Grützkau
Journal:  Eur J Immunol       Date:  2019-09-05       Impact factor: 5.532

4.  RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy.

Authors:  Adrian P Wiegmans; Mariska Miranda; Shu Wen Wen; Fares Al-Ejeh; Andreas Möller
Journal:  Oncotarget       Date:  2016-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.